PEKANA Naturheilmittel GmbH develops, manufactures and distributes natural remedies with a focus on pharmaceuticals; the portfolio also includes cosmetics and medical devices. The product range covers a broad spectrum of indications and is offered particularly in the dosage forms drops, ointments, globules and tablets. The company is active worldwide with its most important sales markets being Germany, the USA and India and an export ratio of around 67% in 2024. The company is based in Kisslegg; PEKANA takes sustainability aspects into account and is a member of the Climate Alliance Baden-Wuerttemberg. PEKANA Naturheilmittel GmbH is a family business.
Herstellung und Vertrieb von a. pharmazeutischen und veterinärmedizinischen Produkten - Homöopathisch; homöopathisch-spagyrischen, phytotherapeutischen Arzneimitteln - Nahrungsergänzungsmittel und diätetische Erzeugnisse für medizinische und nichtmedizinische Zwecke auf der Basis von Vitaminen, Mineralstoffen und/oder Spurenelementen, Proteinen und/oder Kohlehydraten: - sonstige pharmazeutische und veterinärmedizinische Erzeugnisse sowie Präparate für die Gesundheitspflege b. Kosmetische Produkte - Seifen, Parfümerien, ätherische Öle, Mittel zur Körper- und Schönheitspflege; - sowie sonstige Kosmetikprodukte
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 620333 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Katharina Beyersdorff | Geschäftsführer(in) | Kißlegg |
| Marius Beyersdorff | Geschäftsführer(in) | Kißlegg |
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 620333 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €8,006,267 | €143,577 | €12,037,025 | — |
| 2023 | €8,333,233 | €35,863 | €11,551,085 | — |
| 2022 | Rohergebnis€5.8M2 | -€159,129 | €11,887,377 | — |
| 2021 | €7,856,941 | €338,020 | €11,298,488 | — |
| 2020 | €7,611,936 | €317,608 | €9,195,070 | — |
| 2019 | €7,399,474 | €374,028 | €8,656,529 | — |
| 2018 | ≤ €12M1 | €283,489 | €8,712,902 | — |
| 2017 | ≤ €12M1 | €34,501 | €8,387,566 | — |
| 2016 | ≤ €12M1 | €342,486 | €7,963,256 | — |
| 2015 | ≤ €12M1 | €191,054 | €7,522,482 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 620333 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Cost of Goods Sold | €4,934,018 | 65.5% |
| Selling Costs | €1,791,467 | 23.8% |
| Admin Costs | €805,259 | 10.7% |
